Literature DB >> 17158633

Association of cardiovascular risk factors and disease with depression in later life.

Osvaldo P Almeida1, Leon Flicker, Paul Norman, Graeme J Hankey, Samuel Vasikaran, Frank M van Bockxmeer, Konrad Jamrozik.   

Abstract

OBJECTIVE: The objective of this study is to determine the association between established cardiovascular risk factors and depression among older men.
METHODS: The authors conducted a cross-sectional study of a community-representative sample of 5,439 men aged 71-89 years. Cardiovascular disease and risk factors assessed included history of diabetes, hypertension, angina, myocardial infarction, and stroke; current smoking; total cholesterol and fractions; triglycerides; total plasma homocysteine; and MTHFR677 genotype. Depression was defined by a Geriatric Depression Scale 15 items score of 7 or greater.
RESULTS: A complete data set was available for 4,204 men, of whom 212 were depressed (5%). Men who were depressed reported higher frequency of diabetes (23.1% versus 13.2%), angina (30.2% versus 20.4%), myocardial infarction (26.2% versus 16.0%), and stroke (23.6% versus 9.1%) than nondepressed men. Participants with depression were also more likely to have plasma homocysteine above 15 mumol/L (39.1% versus 25.5%) and high triglycerides (32.1% versus 20.9%) than nondepressed subjects. Depressed older men were also more likely to be active smokers (9.9% versus 4.8%). The other factors measured in the study were not significantly associated with depression. Estimation of the population-attributable fraction (PAF) after logistic regression showed that high plasma homocysteine had the highest PAF for depression (PAF:15%, 95% confidence interval [95% CI]: 5%-23%) followed by high triglycerides (PAF: 11%, 95% CI: 2%-18%), angina (PAF: 9%, 95% CI: 2%-15%), stroke (PAF: 8%, 95% CI: 3%-13%), diabetes (PAF: 7%, 95% CI: 1%-13%), myocardial infarction (PAF: 5%, 95% CI: 0%-11%), and smoking (PAF: 5%, 95% CI: 1%-9%).
CONCLUSIONS: High plasma homocysteine and triglycerides appear to account for a considerable proportion of cases of depression in older men. The successful management of these risk factors may contribute to decrease the prevalence of depression in later life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158633     DOI: 10.1097/01.JGP.0000246869.49892.77

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  23 in total

Review 1.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

2.  The association of depression and angina pectoris across 47 countries: findings from the 2002 World Health Survey.

Authors:  Adrian Loerbroks; Jos Antonio Bosch; Paula Maria Christina Mommersteeg; Raphael Manfred Herr; Peter Angerer; Jian Li
Journal:  Eur J Epidemiol       Date:  2014-06-22       Impact factor: 8.082

3.  Angiogenesis inhibition and depression in older men.

Authors:  Osvaldo P Almeida; Andrew H Ford; Leon Flicker; Graeme J Hankey; Bu B Yeap; Paula Clancy; Jonathan Golledge
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

4.  Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients.

Authors:  Gualberto Ruaño; David Villagra; Bonnie Szarek; Andreas Windemuth; Mohan Kocherla; Krystyna Gorowski; Christopher Berrezueta; Harold I Schwartz; John Goethe
Journal:  Biomark Med       Date:  2011-08       Impact factor: 2.851

5.  Prevalence and correlates of poor self-rated health in the United States: the national elder mistreatment study.

Authors:  Ananda B Amstadter; Angela Moreland Begle; Josh M Cisler; Melba A Hernandez; Wendy Muzzy; Ron Acierno
Journal:  Am J Geriatr Psychiatry       Date:  2010-07       Impact factor: 4.105

6.  Depression, antidepressant use and mortality in later life: the Health In Men Study.

Authors:  Osvaldo P Almeida; Helman Alfonso; Graeme J Hankey; Leon Flicker
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

Review 7.  Depression and serum low-density lipoprotein: A systematic review and meta-analysis.

Authors:  Jane E Persons; Jess G Fiedorowicz
Journal:  J Affect Disord       Date:  2016-07-19       Impact factor: 4.839

8.  Plasma Amyloid-β Peptides and Homocysteine in Depression in the Homebound Elderly.

Authors:  Wei Qiao Qiu; Xiaoyan Sun; D Mkaya Mwamburi; Jacqueline Haker; David Lisle; Abishek Rizal; Yu-Min Lin; Liyan Qiao; Paul Summergrad; Marshal Folstein; Irwin Rosenberg
Journal:  N Am J Med Sci (Boston)       Date:  2010-04

9.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16

10.  The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life.

Authors:  Andrew H Ford; Leon Flicker; Kieran McCaul; Frank van Bockxmeer; Sarah Hegarty; Varsha Hirani; Stephen Fenner; Osvaldo P Almeida
Journal:  Trials       Date:  2010-01-25       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.